PZ6-12499-70738
3 vaccinations
4 coded responses
14 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 018 / MA
- Registered
- 2022-07-22
- Relationship
- Child or adolescent in my care
- Guardian
- QVJ-20957-43179
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-22
Registered in v-safe
-
2022-10-20
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Site: Pain, Redness · NoneUnder 3 check-in
- 2022-10-26
- 2022-11-03
-
2022-11-10
Dose 2 — Pfizer-BioNTech
-
2022-11-10
Health check-in — day 0, dose 2, under 3Feeling: Fair · Site: Pain, Redness · NoneUnder 3 check-in
-
2022-11-11
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-11-12
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Redness · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-11-14
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Redness · Irritability/cryingUnder 3 check-in
- 2022-11-17
-
2022-11-26
Survey response — day 14, dose 2, under 3MedDRA: Cough, Irritability, Rhinorrhoea — Feeling: PoorFree text: Cough, irritability, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
-
2022-12-08
Survey response — day 28, dose 2, under 3MedDRA: Abdominal pain upper, Diarrhoea — Feeling: FairFree text: Stomach ache and loose stoolMedDRA releases: 2024-11 · check-in free text available
-
2022-12-15
Survey response — day 35, dose 2, under 3MedDRA: Erythema multiforme, Hypersensitivity, Self-medication — Feeling: Fair · Be unable to work or attend schoolFree text: Experienced some sort of histamine reaction. Diagnosed with Erythema multiforme. With an unknown cause. She's on a course of predisolone and daily Zyrtec.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Health check-in — day 42, dose 2, under 3Feeling: Poor · Be unable to do your normal daily activitiesFree text: Crusty eyes, slight fever, runny/stuffy nose, flushed face, minor breakout around mouthUnder 3 check-in · check-in free text available
-
2023-01-05
Dose 3 — Pfizer-BioNTech
-
2023-02-09
Survey response — 3 months, dose 2, under 3MedDRA: Erythema multiforme, Gastroenteritis viral, Hordeolum, Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-20 | Pfizer-BioNTech | Flu |
| 2 | 2022-11-10 | Pfizer-BioNTech | No |
| 3 | 2023-01-05 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Cough, irritability, runny nose
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Stomach ache and loose stool
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Experienced some sort of histamine reaction. Diagnosed with Erythema multiforme. With an unknown cause. She's on a course of predisolone and daily Zyrtec.
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Crusty eyes, slight fever, runny/stuffy nose, flushed face, minor breakout around mouth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Erythema multiforme | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Hordeolum | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release